How does immunotherapy help us treat cancer?
Join oncologist and researcher Samra Turajlić as she explores why immunotherapy can be so effective for some people with cancer, but cause severe side effects or fail to work in others.
Immunotherapy has transformed the treatment of some cancers by helping the body’s own immune system recognise and attack tumour cells. In this talk, Samra Turajlić explains how these treatments work, why they have been so successful for certain cancers such as melanoma, and why many patients still do not benefit and experience severe side effects.
She also describes her team’s ongoing research at the Crick and the Cancer Research UK Manchester Institute to understand why immunotherapy sometimes fails, and how more personalised approaches – including cancer vaccines – could improve outcomes for more patients in the future.
Samra is a clinician scientist, dividing her time between the lab and the clinic. She is director of the Cancer Research UK Manchester Institute, a visiting group leader in the Cancer Dyanamics Lab at the Francis Crick Institute, and a Consultant Medical Oncologist at The Christie NHS Foundation Trust.
Crick Crash Courses started life as talks for our staff, to help everyone working here, scientists and non-scientists, better understand the Crick's discovery research into how life works.
We're now opening our doors to our crash course talks, giving everyone, everywhere, the opportunity to hear directly from our scientists as they investigate some of the most complex challenges in human health.
